logo
Select company
Select metric
$ -4.45MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
30
Sector
69
Industry
86
History
85
$ 3.1Close
$ 2.68 - $ 6.09 52-Week Range
Ticker Information

Ticker

LPCN

Company Name

LIPOCINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LIPOCINE INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPCN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 55.76K$ -4.51M$ -4.45M
3/31/2025$ 48.16K$ -5.37M$ -5.32M
12/31/2024$ 41.11K$ 9.03K$ 50.14K
9/30/2024$ 33.54K$ -4.05M$ -4.02M
6/30/2024$ 32.77K$ -8.49M$ -8.45M
3/31/2024$ 32.35K$ -8.97M$ -8.94M
12/31/2023$ 28.66K$ -16.35M$ -16.32M
9/30/2023$ 23.24K$ -16.3M$ -16.28M
6/30/2023$ 18.07K$ -12.06M$ -12.04M
3/31/2023$ 12.55K$ -11.13M$ -11.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIPOCINE INC's latest trailing twelve months (TTM) EBITDA stands at $ -20.05M.
  • Over the past 5 years, LIPOCINE INC's average EBITDA has been $ -9.3M.
  • The median EBITDA for LIPOCINE INC during this period was $ -9.83M
  • LIPOCINE INC reached its highest EBITDA over the past 5 years at $ 4.16M.
  • The lowest EBITDA recorded by LIPOCINE INC in the same timeframe $ -20.57M

LIPOCINE INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
MRKR : MARKER THERAPEUTICS INC $ -14.56MBOLT : BOLT BIOTHERAPEUTICS INC $ -47.13MTRAW : TRAWS PHARMA INC $ 87.92MNRXS : NEURAXIS INC $ -7.03MLGVN : LONGEVERON INC $ -17.38MXAIR : BEYOND AIR INC $ -35.84MDYAI : DYADIC INTERNATIONAL INC $ -5.09MINM : INMED PHARMACEUTICALS INC $ -7.26MLEXX : LEXARIA BIOSCIENCE CORP $ -11.27MINBS : INTELLIGENT BIO SOLUTIONS INC $ -9.29M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for LIPOCINE INC is calculated as follows: EBIT [ $ -20.05M ] + DepAmor [ $ 6.26K ]
(=) EBITDA [ $ -20.05M ]

LPCN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -20.57M

Minimum

Dec 31, 2020

$ 4.16M

Maximum

Sep 30, 2022

$ -9.3M

Average

$ -9.83M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M